Maria F Gonzalez-Aponte

6PUBLICATIONS
21CO-AUTHORS
Gene and molecular therapyHaematological tumoursRegenerative medicine (incl. stem cells)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Oct 22, 2025
Circadian variation in MGMT promoter methylation and expression predicts sensitivity to temozolomide in glioblastoma.

Maria F Gonzalez-Aponte, Yitong Huang, William A Leidig

|May 28, 2025
Tracking Daily Variations in Rest-Wake to Guide Personalized Timing of Temozolomide for High-Grade Glioma Patients.

Maria F Gonzalez-Aponte, Anna R Damato, Ruth G N Katumba

|Feb 07, 2025
A synthetic chronogenetic gene circuit for programmed circadian drug delivery.

Lara Pferdehirt, Anna R Damato, Kristin L Lenz

|May 20, 2024
Daily glucocorticoids promote glioblastoma growth and circadian synchrony to the host.

Maria F Gonzalez-Aponte, Anna R Damato, Tatiana Simon

|Jan 26, 2024
Circadian regulation of MGMT expression and promoter methylation underlies daily rhythms in TMZ sensitivity in glioblastoma.

Maria F Gonzalez-Aponte, Anna R Damato, Laura Lucía Trebucq

|Sep 25, 2023
Circadian regulation of MGMT expression and promoter methylation underlies daily rhythms in TMZ sensitivity in glioblastoma.

Maria F Gonzalez-Aponte, Anna R Damato, Laura Lucía Trebucq

Pageof 1